National Cancer Institute

Rio de Janeiro 20220-410

1 studies enrolling now · 4 studies all time

What they study most

Advanced Melanoma, Graft-versus-Host Disease, Select Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) — Recruiting now
• Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors — Running, not enrolling
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease — Completed